Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia
Status:
Terminated
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical efficacy of azithromycin, used as a
quorum-sensing blocker, when compared to placebo for preventing or delaying the occurrence of
pneumonia in ventilated patients colonized with Pseudomonas aeruginosa.